Cargando…
Expensive lifesaving treatments: allocating resources and maximizing access
Avisar et al. present an exemplary model for outreach aimed at ensuring that a maximum of patients eligible for expensive Hepatitis C (HPC) drugs receive treatment. We enlarge the picture to put their model in the political, economic and regulatory framework for financing and providing these drugs i...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753539/ https://www.ncbi.nlm.nih.gov/pubmed/29298723 http://dx.doi.org/10.1186/s13584-017-0195-7 |